Endo Loses Bid to Stop Sales of Generic Painkiller Rivals

Endo Health Solutions Inc., the maker of the painkillers Percocet and Lidoderm, lost an effort to stop U.S. sales of generic versions of its extended-release pill Opana that don’t have tamper-resistant qualities.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.